Skip to main content

Table 1 Clinical characteristics of patients with lung cancer

From: Change in cytokine profiles released by mast cells mediated by lung cancer-derived exosome activation may contribute to cancer-associated coagulation disorders

  

Thrombus(n=17)

Non-thrombus(n=50)

P

Gender

    
 

Male

6 (35.3%)

24 (48%)

0.363

 

Female

11 (64.7%)

26 (52%)

 

Age, years

    
  

65.94 ± 6.088

65.34 ± 12.79

0.599

Smoking history

    
 

Yes

3 (17.6%)

1 (2%)

0.078

 

No

14 (82.4%)

49 (98%)

 

Chemotherapy history

    
 

Yes

15 (88.2%)

35 (70%)

0.242

 

No

2 (11.8%)

15 (30%)

 

Target therapy

    
 

Yes

8 (47.1%)

26 (52%)

0.725

 

No

9 (52.9%)

24 (48%)

 

Immunotherapy

    
 

Yes

2 (11.8%)

11 (22%)

0.571

 

No

15 (88.2%)

39 (78%)

 

Histology

    
 

Squamous carcinoma

2 (11.8%)

10 (20%)

0.025

 

Adenocarcinoma

11 (64.7%)

39 (78%)

 
 

Other

4 (23.5%)

1 (2%)

 

Stage

    
 

I

1 (5.9%)

3 (6%)

0.328

 

II

1 (5.9%)

3 (6%)

 
 

III

5 (29.4%)

5 (10%)

 
 

IV

10 (58.8%)

39 (78%)

 

T

    
 

1

3 (17.6%)

9 (18%)

0.661

 

2

4 (23.5%)

13 (26%)

 
 

3

4 (23.5%)

5 (10%)

 
 

4

6 (35.3%)

20 (40%)

 

N

    
 

0

1 (5.9%)

6 (12%)

0.543

 

1

1 (5.9%)

7 (14%)

 
 

2

5 (29.4%)

9 (18%)

 
 

3

10 (58.8%)

26 (52%)

 

Metastasis

    
 

Yes

8 (50%)

13 (65%)

0.500

 

No

8 (50%)

7 (35%)

 
  1. Data are expressed as the number of patients (%) or means ± standard deviation. Differences between the two groups were compared using the Chi-square test for categorical variables and Mann-Whitney's U test for the non-normally distributed continuous variable (age)
Back to article page

Cell Communication and Signaling

ISSN: 1478-811X